Xanthic Plaques - Causes, Treatment & When to See a Doctor

```html

What is Xanthic Plaques?

Xanthic plaques (also called xanthomas) are yellow‑to‑orange, often slightly raised lesions that develop in the skin, tendons, or around the eyes. They arise when fatty substances, primarily cholesterol and triglycerides, build up within cells of the dermis (the deeper layer of the skin). The word “xanthic” derives from the Greek xanthos, meaning “yellow.” While most xanthic plaques are harmless cosmetically, they can be an external clue to serious underlying lipid (fat) disorders, liver disease, or metabolic conditions.

Common Causes

Various medical conditions can lead to the formation of xanthic plaques. Below are the most frequent:

• Familial Hypercholesterolemia (FH) – an inherited defect in LDL‑receptor function that raises LDL‑cholesterol from birth.
• Mixed Hyperlipidemia – elevated LDL and triglycerides, often linked to diet, obesity, and metabolic syndrome.
• Primary Biliary Cholangitis (PBC) – chronic autoimmune liver disease causing cholestasis and lipid abnormalities.
• Familial Dysbetalipoproteinemia (Type III hyperlipoproteinemia) – defective ApoE leads to accumulation of remnant lipoproteins.
• Diabetes Mellitus (especially poorly controlled) – dyslipidemia and glycation of skin proteins predispose to plaques.
• Nephrotic Syndrome – massive protein loss triggers hepatic over‑production of lipoproteins.
• Hypothyroidism – reduced LDL‑receptor activity raises serum cholesterol.
• Chronic alcohol‑related liver disease – impairs lipid metabolism, leading to “xanthoma striatum palmaris.”
• Medication‑induced hyperlipidemia – e.g., protease inhibitors, cyclosporine, or glucocorticoids.
• Secondary causes – such as sarcoidosis or granulomatous diseases that alter lipid handling.

Associated Symptoms

While xanthic plaques themselves are usually painless, several other signs often appear alongside them:

• Yellowish deposits around the eyes (xanthelasma).
• Foamy or eruptive lesions on the trunk and extremities (eruptive xanthomas).
• Thickened, yellowish tendons—most often the Achilles tendon (tendon xanthoma).
• Abdominal pain or hepatomegaly in liver‑related causes.
• Fatigue, weight gain, or cold intolerance with hypothyroidism.
• Proteinuria or swelling (edema) in nephrotic syndrome.
• Burning or itching sensation if plaques become inflamed.

When to See a Doctor

Because xanthic plaques can signal systemic disease, you should schedule an evaluation if you notice any of the following:

• New‑onset plaques, especially if they appear on the hands, elbows, knees, or around the eyes.
• Rapid increase in the number or size of lesions.
• Family history of premature heart disease, high cholesterol, or similar skin lesions.
• Accompanying symptoms such as chest pain, shortness of breath, or unexplained fatigue.
• Signs of liver disease (jaundice, dark urine, abdominal swelling) or kidney disease (frothy urine, swelling).
• Any plaque that becomes painful, ulcerated, or infected.

Diagnosis

Evaluation consists of a focused skin examination plus targeted laboratory and imaging studies.

1. Clinical Examination

• Visual inspection of plaques: color, size, distribution, and depth.
• Palpation for consistency (soft vs. firm) and tenderness.
• Assessment for tendon involvement (e.g., Achilles tendon thickening).

2. Laboratory Tests

• Lipid panel: total cholesterol, LDL‑C, HDL‑C, triglycerides.
• Thyroid‑stimulating hormone (TSH) and free T4 to rule out hypothyroidism.
• Liver function tests (AST, ALT, ALP, bilirubin) and alkaline phosphatase for cholestasis.
• Urinalysis and serum albumin to detect nephrotic syndrome.
• Fasting glucose/HbA1c for diabetes screening.

3. Imaging & Specialized Tests

• Ultrasound or MRI of tendons if tendon xanthomas are suspected.
• Genetic testing for familial hypercholesterolemia (LDLR, APOB, PCSK9 mutations) when indicated.
• Skin biopsy (rarely needed) – histology shows lipid‑laden macrophages (foam cells).

Treatment Options

Therapy is two‑fold: address the underlying metabolic abnormality and manage the skin lesions.

1. Lifestyle Modifications

• Diet: Adopt a heart‑healthy diet—rich in fruits, vegetables, whole grains, and lean protein; limit saturated fat, trans‑fat, and refined sugars.
• Physical activity: Aim for ≥150 minutes of moderate aerobic exercise per week.
• Weight management: Reducing BMI by 5–10 % often lowers LDL and triglycerides.
• Alcohol moderation: Excess alcohol can raise triglycerides and worsen liver disease.
• Quit smoking: Smoking accelerates atherosclerosis and impairs lipid metabolism.

2. Pharmacologic Therapy

• Statins (e.g., atorvastatin, rosuvastatin): First‑line for lowering LDL‑C; also modestly reduce triglycerides.
• Ezetimibe: Blocks intestinal cholesterol absorption; useful when statins are insufficient.
• PCSK9 inhibitors (evolocumab, alirocumab): Strong LDL‑lowering agents for familial hypercholesterolemia.
• Fibrates (gemfibrozil, fenofibrate): Primarily lower triglycerides and raise HDL‑C; indicated for eruptive xanthomas.
• Niacin: Can reduce VLDL and raise HDL, but side‑effects limit use.
• Omega‑3 fatty acid supplements: EPA/DHA (prescription‑strength 2–4 g daily) lower triglycerides.
• Thyroid hormone replacement: For hypothyroidism, normalizing TSH often resolves plaques.
• Ursodeoxycholic acid or other cholestasis‑directed drugs: For primary biliary cholangitis.

3. Dermatologic Procedures

• Laser therapy (e.g., CO₂ or pulsed dye laser): Can fade superficial plaques.
• Cryotherapy: Freezing small lesions; reserved for isolated eruptive xanthomas.
• Surgical excision: Considered for large, cosmetically distressing plaques that do not respond to medical therapy.

4. Monitoring & Follow‑up

Regular lipid panels (every 3–6 months initially) and clinical skin checks are essential to gauge response and adjust therapy. Patients with genetic lipid disorders should remain under lifelong specialist care (cardiology or lipidology).

Prevention Tips

• Start a heart‑healthy diet early—Mediterranean or DASH patterns are evidence‑based.
• Maintain an active lifestyle; even brisk walking reduces LDL‑C.
• Screen family members if you are diagnosed with FH or another inherited lipid disorder.
• Keep routine health checks: annual lipid panel after age 20, and earlier if family history suggests risk.
• Control blood sugar and blood pressure—metabolic syndrome fuels dyslipidemia.
• Avoid excessive alcohol and tobacco.
• If you take medications known to raise lipids, discuss monitoring or alternatives with your prescriber.

Emergency Warning Signs

Key Take‑aways

Xanthic plaques are more than a cosmetic issue; they are a visible marker of underlying lipid or metabolic disturbances that can predispose to cardiovascular disease, liver problems, and kidney disease. Prompt evaluation, lifestyle optimization, and targeted medication often shrink or eliminate the plaques while dramatically lowering long‑term health risks. Always discuss new or changing skin lesions with a healthcare professional, especially if you have a personal or family history of heart disease, diabetes, or liver/kidney disorders.

References:

• Mayo Clinic. “Xanthoma.” https://www.mayoclinic.org
• National Heart, Lung, & Blood Institute. “Familial Hypercholesterolemia.” https://www.nhlbi.nih.gov
• American College of Cardiology. “Guidelines for the Management of Dyslipidemia.” 2023.
• Cleveland Clinic. “Xanthomas: Types, Causes, Treatment.” https://my.clevelandclinic.org
• World Health Organization. “WHO Guideline on the Management of Hyperlipidaemia.” 2022.

```